mebendazole has been researched along with Shock, Cardiogenic in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rein, R | 1 |
| Niggemann, B | 1 |
| Runge, M | 1 |
1 other study available for mebendazole and Shock, Cardiogenic
| Article | Year |
|---|---|
[Echinococcosis of the heart].
Topics: Adult; Antinematodal Agents; Cardiac Tamponade; Cardiomyopathies; Combined Modality Therapy; Diagnos | 1996 |